{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T13:03:09Z","timestamp":1765458189512,"version":"3.46.0"},"reference-count":52,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cardiovascular diseases have become a leading global health burden, with rising mortality worldwide. WNT and JAK\/STAT have been highlighted as emerging biomarkers in cardiovascular disease pathogenesis. This study assessed the Wnt\/JAK-STAT signaling pathway in relation to SFRP5 and genetic polymorphisms in cardiac patients. This prospective case\u2013control study included 100 patients with various cardiac diseases (IHD, valvular heart disease, HF, cardiomyopathy, and arrhythmia) and 50 matched healthy controls. Clinical and echocardiographic assessments were performed. Plasma SFRP5, Wnt5a, and JAK levels were measured using ELISA; STAT5A expression by flow cytometry; and SFRP5 (rs780369540) gene polymorphism by TaqMan real-time PCR were also performed in all participants. Cardiac patients showed significantly higher median BMI (33 vs. 28.5 kg\/m2, p = 0.001) and markedly increased median value of each Wnt5a (16.85 vs. 5.6 pg\/mL, p &lt; 0.001), median JAK (9.45 vs. 2.4 pg\/mL, p &lt; 0.001), and STAT5A expression (87.55% vs. 33%, p &lt; 0.001), with lower SFRP5 levels (4 vs. 6.7 ng\/L, p &lt; 0.001) compared to control. The SFRP5 (rs780369540) T allele was more frequent in patients (51.5% vs. 32%, p = 0.001), and dominant TT + TC genotypes were higher (66% vs. 42%, p = 0.005) compared to the control group. TT carriers showed higher median Wnt5a, lower median SFRP5, and reduced ejection fraction compared to other genotypes (TC, CC) carriers. Multivariate analysis identified elevated Wnt5a, JAK, and decreased SFRP5 as independent predictors of cardiovascular disease (p &lt; 0.05). Cardiac patients showed altered WNT5a, JAK, and SFRP5 levels. SFRP5 polymorphism predicted cardiovascular risk independently.<\/jats:p>","DOI":"10.3390\/ijms262411943","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T12:57:41Z","timestamp":1765457861000},"page":"11943","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessments of Wnt\/JAK-STAT Signaling Pathway in Relation to Sfrp5 Among Patients with Cardiac Diseases"],"prefix":"10.3390","volume":"26","author":[{"given":"Mohammed H.","family":"Hassan","sequence":"first","affiliation":[{"name":"Department of Medical Biochemistry & Molecular Biology, Faculty of Medicine, Qena University, Qena 83523, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sawsan M. A.","family":"Abuhamdah","sequence":"additional","affiliation":[{"name":"Department of Biopharmaceutics and Clinical Pharmacy, School of Pharmacy, The University of Jordan, Amman 11942, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omyma Ashraf","family":"Hasan","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry & Molecular Biology, Faculty of Medicine, Qena University, Qena 83523, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"AK","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, Qena University, Qena 83523, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmaa","family":"Nafady","sequence":"additional","affiliation":[{"name":"Department of Clinical and Chemical Pathology, Faculty of Medicine, Qena University, Qena 83523, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nehal Ashraf","family":"Zaki","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry & Molecular Biology, Faculty of Medicine, Qena University, Qena 83523, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa","family":"Abdelhady","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Luxor University, Luxor 85951, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rana","family":"Toghan","sequence":"additional","affiliation":[{"name":"Department of Medical Physiology, Faculty of Medicine, Qena University, Qena 83523, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahia H.","family":"Saleem","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry & Molecular Biology, Faculty of Medicine, Assuit University, Assuit 71515, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e18753183297843","DOI":"10.2174\/0118753183297843240905081014","article-title":"New horizons in the study of WNT and JAK\/STAT signaling pathways in cardiometabolic diseases","volume":"14","author":"Anatolyevna","year":"2024","journal-title":"Open Biomark. J."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Henein, M.Y., Vancheri, S., Longo, G., and Vancheri, F. (2022). The role of inflammation in cardiovascular disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232112906"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e029971","DOI":"10.1161\/JAHA.123.029971","article-title":"Acute myocardial infarction: Etiologies and mimickers in young patients","volume":"12","author":"Krittanawong","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Huang, X., Yan, Y., Zheng, W., Ma, Y., Wang, X., Gong, W., and Nie, S. (2021). Secreted frizzled-related protein 5 protects against cardiac rupture and improves cardiac function through inhibiting mitochondrial dysfunction. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.682409"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Jiang, H., Yang, J., Li, T., Wang, X., Fan, Z., Ye, Q., and Du, Y. (2024). JAK\/STAT3 signaling in cardiac fibrosis: A promising therapeutic target. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1336102"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Ilic, I., and Ilic, M. (2021). Risk factors for myocardial infarction in women and men: A case-control study. Biol. Life Sci. Forum, 9.","DOI":"10.3390\/ECCM-10876"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Li, Z., Gu, Z., Xiang, J., and Zhang, X. (2025). Clinical characteristics and influencing factors of cardiovascular comorbidities in psoriasis. Front. Cardiovasc. Med., 12.","DOI":"10.3389\/fcvm.2025.1586731"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"719","DOI":"10.6026\/973206300200719","article-title":"Smoking is a predominant risk factor for coronary artery disease among Indians","volume":"20","author":"Taqiuddin","year":"2024","journal-title":"Bioinformation"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"E503","DOI":"10.21037\/jtd.2017.04.30","article-title":"Gender differences in cardiovascular risk factors in patients with coronary artery disease and those with type 2 diabetes","volume":"9","author":"Wakabayashi","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/1995-705X.81547","article-title":"Smoking effect on ischemic heart disease in young patients","volume":"12","author":"Hbejan","year":"2011","journal-title":"Heart Views"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1002\/ehf2.14828","article-title":"Artificial intelligence-assisted automated heart failure detection and classification from electronic health records","volume":"11","author":"Oo","year":"2024","journal-title":"ESC Heart Fail."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.12688\/wellcomeopenres.15829.2","article-title":"Family history of cardiovascular disease and risk of premature coronary heart disease: A matched case-control study","volume":"5","author":"Chacko","year":"2020","journal-title":"Wellcome Open Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.37765\/ajmc.2024.89670","article-title":"An overview of cardiovascular-kidney-metabolic syndrome","volume":"30","author":"Ferdinand","year":"2024","journal-title":"Am. J. Manag. Care"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Mutruc, V., Bologa, C., \u0218orodoc, V., Ceasovschih, A., Mor\u0103ra\u0219u, B.C., \u0218orodoc, L., Catar, O.E., and Lionte, C. (2025). Cardiovascular\u2013kidney\u2013metabolic syndrome: A new paradigm in clinical medicine or going back to basics?. J. Clin. Med., 14.","DOI":"10.3390\/jcm14082833"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Cunillera-Pu\u00e9rtolas, O., Vizcaya, D., Cerain-Herrero, M.J., Gil-Terr\u00f3n, N., Cobo-Guerrero, S., and Salvador-Gonz\u00e1lez, B. (2022). Cardiovascular events and mortality in chronic kidney disease in primary care patients with previous type 2 diabetes and\/or hypertension: A population-based epidemiological study (KIDNEES). BMC Nephrol., 23.","DOI":"10.1186\/s12882-022-02966-6"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1605635","DOI":"10.3389\/ijph.2023.1605635","article-title":"Prevalence, cardiometabolic comorbidities and reporting of chronic kidney disease: A Hungarian cohort analysis","volume":"68","author":"Wittmann","year":"2023","journal-title":"Int. J. Public Health"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000520909","article-title":"Heart failure in patients with diabetes and chronic kidney disease: Challenges and opportunities","volume":"12","author":"Vijay","year":"2022","journal-title":"Cardiorenal Med."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Tang, J., Hu, S., Liu, X., Li, H., Kuang, L., Zhang, L., Cao, W., Zhang, T., Guan, X., and Li, L. (2024). Global, regional, and national time trends in ischaemic heart disease incidence over three decades (1990\u20132019): An age-period-cohort analysis of the Global Burden of Disease Study 2019. Front. Cardiovasc. Med., 11.","DOI":"10.3389\/fcvm.2024.1396380"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Malmborg, M., Al-Kahwa, A.T.A., Kober, L., Torp-Pedersen, C., Butt, J.H., Zahir, D., Tuxen, C.D., Poulsen, M.K., Madelaire, C., and Fosbol, E. (2023). Specialized heart failure clinics versus primary care: Extended registry-based follow-up of the NorthStar trial. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0286307"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e010133","DOI":"10.1161\/CIRCOUTCOMES.123.010133","article-title":"Mapping geographic proximity to cardiologists across the United States","volume":"16","author":"Motairek","year":"2023","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.jacc.2022.02.001","article-title":"Comparison of American and European Guidelines for Primary Prevention of Cardiovascular Disease: JACC Guideline Comparison","volume":"79","author":"Gianos","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"ESC guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/2047487313480435","article-title":"Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: A network meta-analysis","volume":"20","author":"Naci","year":"2013","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e003529","DOI":"10.1161\/CIRCHEARTFAILURE.116.003529","article-title":"Thirty years of evidence on the efficacy of drug treatments for chronic heart failure with reduced ejection fraction","volume":"10","author":"Burnett","year":"2017","journal-title":"Circ. Heart Fail."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/1753944716644131","article-title":"Mega clinical trials which have shaped the RAS intervention clinical practice","volume":"10","year":"2016","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/joa3.12556","article-title":"Association between atrial fibrillation and bundle branch block","volume":"37","author":"Khan","year":"2021","journal-title":"J. Arrhythmia"},{"key":"ref_27","first-page":"170","article-title":"Natural history and clinical significance of isolated complete left bundle branch block without associated structural heart disease","volume":"25","author":"Ashraf","year":"2021","journal-title":"Anatol. J. Cardiol."},{"key":"ref_28","first-page":"467","article-title":"Atrial fibrillation associated with heart failure, stroke and mortality","volume":"5","author":"Bordignon","year":"2012","journal-title":"J. Atrial Fibrill."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e001193","DOI":"10.1161\/JAHA.114.001193","article-title":"Left ventricular diameter and risk stratification for sudden cardiac death","volume":"3","author":"Narayanan","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41572-019-0084-1","article-title":"Dilated cardiomyopathy","volume":"5","author":"Schultheiss","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1093\/eurheartj\/ehac223","article-title":"Left ventricular remodelling post-myocardial infarction: Pathophysiology, imaging, and novel therapies","volume":"43","author":"Frantz","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jacc.2008.12.007","article-title":"Heart failure with normal left ventricular ejection fraction","volume":"53","author":"Maeder","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e040490","DOI":"10.1161\/JAHA.124.040490","article-title":"Association between size of left ventricle and long-term cardiovascular events","volume":"14","author":"Cheng","year":"2025","journal-title":"J. Am. Heart Assoc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"101444","DOI":"10.1016\/j.jacadv.2024.101444","article-title":"Small heart size and premature death in 366,484 individuals with normal ejection fraction","volume":"4","author":"Rowe","year":"2025","journal-title":"JACC Adv."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1047951124026052","article-title":"The role of diagnostic modalities in differentiating hypertensive heart disease and hypertrophic cardiomyopathy: Strategies in adults for potential application in paediatrics","volume":"35","author":"Wagner","year":"2025","journal-title":"Cardiol. Young"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Yang, Y., Li, Z., Guo, X., Zhou, Y., Chang, Y., Yang, H., Yu, S., Ouyang, N., Chen, S., and Sun, G. (2022). Interventricular septum thickness for the prediction of coronary heart disease and myocardial infarction in hypertension population: A prospective study. J. Clin. Med., 11.","DOI":"10.3390\/jcm11237152"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"AP396","DOI":"10.1161\/res.129.suppl_1.P396","article-title":"Noncanonical Wnt5a increases QT interval and susceptibility to ventricular arrhythmias","volume":"129","author":"Wang","year":"2021","journal-title":"Circ. Res."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Kelly, C., Chu, M., Untaru, R., Assadi-Khansari, B., Chen, D., Croft, A.J., Horowitz, J.D., Boyle, A.J., Sverdlov, A.L., and Ngo, D.T.M. (2023). Association of circulating plasma secreted frizzled-related protein 5 (Sfrp5) levels with cardiac function. J. Cardiovasc. Dev. Dis., 10.","DOI":"10.3390\/jcdd10070274"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"868","DOI":"10.5551\/jat.47019","article-title":"High serum secreted frizzled-related protein 5 levels associate with early improvement of cardiac function following ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention","volume":"26","author":"Du","year":"2019","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1161\/CIRCRESAHA.111.259556","article-title":"STAT5 activation and cardioprotection by remote ischemic preconditioning in humans: Short communication","volume":"110","author":"Heusch","year":"2012","journal-title":"Circ. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4161\/jkst.20115","article-title":"Roles of STATs signaling in cardiovascular diseases","volume":"1","author":"Kishore","year":"2012","journal-title":"JAK-STAT"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1074\/jbc.M115.693937","article-title":"Secreted frizzled-related protein 5 diminishes cardiac inflammation and protects the heart from ischemia\/reperfusion injury","volume":"291","author":"Nakamura","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_43","first-page":"6305","article-title":"Clinical significance of sFRP5, RBP-4 and NT-proBNP in patients with chronic heart failure","volume":"13","author":"An","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00109-017-1529-1","article-title":"Wnt5a is elevated in heart failure and affects cardiac fibroblast function","volume":"95","author":"Abraityte","year":"2017","journal-title":"J. Mol. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/1440-1681.12258","article-title":"The novel role and underlying mechanism of Wnt5a in regulating cellular cholesterol accumulation","volume":"41","author":"Qin","year":"2014","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"T\u00f3thov\u00e1, Z., Tomc, J., Debeljak, N., and Sol\u00e1r, P. (2021). STAT5 as a key protein of erythropoietin signalization. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22137109"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/jamacardio.2018.0022","article-title":"Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity","volume":"3","author":"Khan","year":"2018","journal-title":"JAMA Cardiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1093\/eurjpc\/zwac187","article-title":"Obesity and cardiovascular disease: Mechanistic insights and management strategies","volume":"29","author":"Almahmeed","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","article-title":"Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: An analysis of the CHARM programme","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur. Heart J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"S640","DOI":"10.1161\/CIRCULATIONAHA.110.970889","article-title":"Part 1: Executive summary: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care","volume":"122","author":"Field","year":"2010","journal-title":"Circulation"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2010.11.006","article-title":"American Society of Echocardiography recommendations for quality echocardiography laboratory operations","volume":"24","author":"Picard","year":"2011","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"AHA\/ACC\/HFSA guideline for the management of heart failure: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/24\/11943\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T12:58:11Z","timestamp":1765457891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/24\/11943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":52,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["ijms262411943"],"URL":"https:\/\/doi.org\/10.3390\/ijms262411943","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2025,12,11]]}}}